New Legislation Aims to Prohibit DIR Fees February 22, 2017 By Christine Blank Bills have been introduced in both the Senate and House that are aimed at stopping direct and indirect remuneration fees, assuming they are passed. New bill aims to support generic, biosimilar drug competition July 06, 2016 By Christine Blank The CREATES Act came about because some pharmaceutical manufacturers are misusing the REMS program to prevent generic drug development. Pharmacy education and provider status A 60-year debate accompanied the elevation of pharmacy education to the doctoral level. When the provider status bill now moving through Congress is enacted into law, it will put paid to that particular conversation. NCPA Congressional Pharmacy Summit advocates for clarity around Rx drug pricing More than 300 pharmacists turned out to support H.R. 244, the “MAC Transparency Act," and H.R. 793, the “Ensuring Seniors Access to Local Pharmacies Act of 2015.” Provider status June 08, 2016 By Fred Gebhart With provider status now a reality in 38 states, HR 592 and S 314 have powerful Congressional support. How long before the payers come on board? Arizona passes pharmacy biosimilar law June 02, 2016 By Christine Blank Arizona recently joined around 20 other states by passing a law allowing pharmacists to substitute certain interchangeable biosimilar drugs for brand name drugs. Pharmacists seek fairness in generics reimbursement May 31, 2016 By Christine Blank PBMs have dodged state-mandated requirements for transparency in generics drug pricing, so many states are rewriting their laws. Below-cost Rxs: One state just says no Starting in July, a new law in Mississippi will allow a pharmacy to refuse to provide drugs or services if it is not paid more than acquisition cost. Pharmacy choice bill dies May 19, 2016 By Christine Blank Independent pharmacists in Colorado are disappointed after a Senate committee killed the “Pharmacy Choice Act” before it could come up for a vote. NACDS, NCPA support passage of drug-abuse bill The law aims to reduce prescription drug abuse while ensuring access for patients who need Rx painkillers to control their chronic pain.